FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3135982018> ?p ?o ?g. }

• W3135982018 endingPage "378" @default.
• W3135982018 startingPage "369" @default.
• W3135982018 abstract "Light-chain amyloidosis (AL-CA) and transthyretin amyloidosis (ATTR-CA) are the most common types of cardiac amyloidosis (CA). We sought to study the clinical characteristics and prognosis of both diseases. We conducted a single-centre, retrospective review of all patients diagnosed with CA between 1998 and 2018. Clinical characteristics, complementary tests, survival and other adverse clinical events were studied. We identified 105 patients with CA, 65 ATTR-CA and 40 AL-CA. Mean age was 74.4 years; 24.8% were women. In both groups, heart failure was the most frequent clinical presentation (55.2%). The most prevalent electrocardiographic findings were the pseudoinfarct pattern (68.5%) and a Sokolow-Lyon index <1.5 mV (67.7%), with no differences between the two subtypes of CA. One-year, 3-year, and 5-year survival was 43.3%, 40.4% and 35.4%, respectively, in AC-AL patients, and 85.1%, 57.3% and 31.4% in AC-ATTR patients (p = .004). AL-CA subtype (HR 3.41, CI95% 1.45−8.06, p = .005), previous admission for heart failure (HR 4.25, 95% CI 1.63−11.09, p = .003) and a NYHA class III-IV (HR 2.76, 95% CI 1.09−7.03, p = .033) were independent predictors of mortality, while beta-blocker therapy was associated with longer survival (HR .23, 95% CI .09–.59, p = .002). Differences exist between the clinical presentation of AL-CA and ATTR-CA patients. Both diseases, particularly AL-CA, are associated with poor life prognosis. La amiloidosis cardiaca (AC) por cadenas ligeras (AC-AL) y por transtirretina (AC-ATTR) son los dos subtipos más frecuentes de la enfermedad. Nos propusimos caracterizar clínicamente estas entidades y analizar su pronóstico. Realizamos una revisión retrospectiva de todos los pacientes diagnosticados de AC entre 1998 y 2018 en un centro español. Además de recoger las características clínicas y los resultados de las pruebas complementarias al diagnóstico, analizamos la supervivencia y la incidencia de desenlaces clínicos adversos. Identificamos 105 pacientes con AC, 65 AC-ATTR y 40 AC-AL. La edad media era de 74,4 años; el 24,8% eran mujeres. En ambos grupos la insuficiencia cardiaca (IC) fue la forma de presentación clínica más frecuente (55,2%). Los hallazgos electrocardiográficos más prevalentes fueron el patrón de pseudoinfarto (68,5%) y un índice de Sokolow-Lyon <1,5 mV (67,7%), sin diferencias entre los dos subtipos. La supervivencia a 1, 3 y 5 años fue del 43,3%, 40,4% y 35,4%, respectivamente, en pacientes con AC-AL y de 85,1%, 57,3% y 31,4% en pacientes con AC-ATTR (p = 0,004). El subtipo AC-AL (HR 3,41, IC95% 1,45-8,06, p = 0,005), el ingreso previo por IC (HR 4,25, IC95% 1,63-11,09, p = 0,003) y una clase NYHA III-IV (HR 2,76, IC95% 1,09-7,03, p = 0,033) fueron predictores independientes de mortalidad, mientras que el tratamiento betabloqueante se asoció con una mayor supervivencia (HR 0,23, IC95% 0,09-0,59, p = 0,002). Existen ciertas diferencias en la presentación clínica de los pacientes con AC-AL y AC-ATTR. Ambas entidades, y muy especialmente la AC-AL, presentan un pobre pronóstico vital." @default.
• W3135982018 created "2021-03-29" @default.
• W3135982018 creator A5005775971 @default.
• W3135982018 creator A5008406124 @default.
• W3135982018 creator A5009303775 @default.
• W3135982018 creator A5026928977 @default.
• W3135982018 creator A5026950886 @default.
• W3135982018 creator A5032367584 @default.
• W3135982018 creator A5042191206 @default.
• W3135982018 creator A5046038275 @default.
• W3135982018 creator A5063438684 @default.
• W3135982018 creator A5065049952 @default.
• W3135982018 creator A5069889348 @default.
• W3135982018 creator A5077229671 @default.
• W3135982018 date "2021-04-01" @default.
• W3135982018 modified "2023-10-18" @default.
• W3135982018 title "Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors" @default.
• W3135982018 cites W1965108537 @default.
• W3135982018 cites W1997525726 @default.
• W3135982018 cites W2046145754 @default.
• W3135982018 cites W2063400022 @default.
• W3135982018 cites W2079055620 @default.
• W3135982018 cites W2097618980 @default.
• W3135982018 cites W2120315236 @default.
• W3135982018 cites W2133199265 @default.
• W3135982018 cites W2163584170 @default.
• W3135982018 cites W2337532627 @default.
• W3135982018 cites W2460856522 @default.
• W3135982018 cites W2465883722 @default.
• W3135982018 cites W2558649598 @default.
• W3135982018 cites W2594063085 @default.
• W3135982018 cites W2609696371 @default.
• W3135982018 cites W2735511149 @default.
• W3135982018 cites W2755151577 @default.
• W3135982018 cites W2922528009 @default.
• W3135982018 cites W2944922806 @default.
• W3135982018 cites W2948364217 @default.
• W3135982018 cites W295053617 @default.
• W3135982018 cites W2953159551 @default.
• W3135982018 cites W2962483508 @default.
• W3135982018 doi "https://doi.org/10.1016/j.medcle.2020.04.036" @default.
• W3135982018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32591181" @default.
• W3135982018 hasPublicationYear "2021" @default.
• W3135982018 type Work @default.
• W3135982018 sameAs 3135982018 @default.
• W3135982018 citedByCount "0" @default.
• W3135982018 crossrefType "journal-article" @default.
• W3135982018 hasAuthorship W3135982018A5005775971 @default.
• W3135982018 hasAuthorship W3135982018A5008406124 @default.
• W3135982018 hasAuthorship W3135982018A5009303775 @default.
• W3135982018 hasAuthorship W3135982018A5026928977 @default.
• W3135982018 hasAuthorship W3135982018A5026950886 @default.
• W3135982018 hasAuthorship W3135982018A5032367584 @default.
• W3135982018 hasAuthorship W3135982018A5042191206 @default.
• W3135982018 hasAuthorship W3135982018A5046038275 @default.
• W3135982018 hasAuthorship W3135982018A5063438684 @default.
• W3135982018 hasAuthorship W3135982018A5065049952 @default.
• W3135982018 hasAuthorship W3135982018A5069889348 @default.
• W3135982018 hasAuthorship W3135982018A5077229671 @default.
• W3135982018 hasBestOaLocation W31359820182 @default.
• W3135982018 hasConcept C121157162 @default.
• W3135982018 hasConcept C126322002 @default.
• W3135982018 hasConcept C159654299 @default.
• W3135982018 hasConcept C163276114 @default.
• W3135982018 hasConcept C164705383 @default.
• W3135982018 hasConcept C167135981 @default.
• W3135982018 hasConcept C197934379 @default.
• W3135982018 hasConcept C203014093 @default.
• W3135982018 hasConcept C2777607188 @default.
• W3135982018 hasConcept C2778198053 @default.
• W3135982018 hasConcept C2779551797 @default.
• W3135982018 hasConcept C2779951007 @default.
• W3135982018 hasConcept C36394416 @default.
• W3135982018 hasConcept C71924100 @default.
• W3135982018 hasConcept C90924648 @default.
• W3135982018 hasConceptScore W3135982018C121157162 @default.
• W3135982018 hasConceptScore W3135982018C126322002 @default.
• W3135982018 hasConceptScore W3135982018C159654299 @default.
• W3135982018 hasConceptScore W3135982018C163276114 @default.
• W3135982018 hasConceptScore W3135982018C164705383 @default.
• W3135982018 hasConceptScore W3135982018C167135981 @default.
• W3135982018 hasConceptScore W3135982018C197934379 @default.
• W3135982018 hasConceptScore W3135982018C203014093 @default.
• W3135982018 hasConceptScore W3135982018C2777607188 @default.
• W3135982018 hasConceptScore W3135982018C2778198053 @default.
• W3135982018 hasConceptScore W3135982018C2779551797 @default.
• W3135982018 hasConceptScore W3135982018C2779951007 @default.
• W3135982018 hasConceptScore W3135982018C36394416 @default.
• W3135982018 hasConceptScore W3135982018C71924100 @default.
• W3135982018 hasConceptScore W3135982018C90924648 @default.
• W3135982018 hasFunder F4320327635 @default.
• W3135982018 hasFunder F4320334923 @default.
• W3135982018 hasIssue "8" @default.
• W3135982018 hasLocation W31359820181 @default.
• W3135982018 hasLocation W31359820182 @default.
• W3135982018 hasOpenAccess W3135982018 @default.
• W3135982018 hasPrimaryLocation W31359820181 @default.
• W3135982018 hasRelatedWork W1078346673 @default.

• next